Innovative R&D in life sciences is gaining momentum in the East with China leading the charge. This is the foundation of my vision for HUYA Bioscience International. I wanted to identify and add value to the wealth of therapeutic opportunities from Chinese institutes and universities.
HUYABIO has now grown to be the leader in globalizing China’s pharmaceutical innovation. Meeting the challenge of tomorrow’s unmet medical needs requires utilizing the talents of Chinese researchers and helping to move their discoveries forward. The HUYABIO teams in San Diego, Tokyo and our eight China offices are committed to building relationships that enable candidate compounds to be more accessible internationally. With diverse approaches including in-licensing, alliances, co-development, research funding and creative financial partnerships, HUYABIO is poised to bring China’s health care discoveries to benefit the rest of the world.
Mireille Gillings, PhD, Hon DSc
CEO and Executive Chair, HUYA Bioscience International